Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) Shareholder Class Action Lawsuit

Our law firm is investigating potential claims on behalf of shareholders of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) over possible violations of US securities laws due to possible false and misleading statements made by the company and its officers. 

If you have purchased shares of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP), call 1-800-934-2921 right now to protect your rights.

 

Our law firm believes that  Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) may have violated US securities laws, and the actions of the company may have caused investors of the company to be negatively affected.

The company has been recently plagued by a number of events that have had an effect on shareholders. CEO Carolyn Logan has recently announced that the board of directors' audit committee is probing Salix's statements regarding its inventory levels, leading to speculation of possible irregularities by the company. Likely related to this, Salix has announced that CFO Adam Derbyshire has resigned. Then, Salix Pharmaceuticals announced that it missed third-quarter earnings and sales forecasts, sending shares plunging.

Our law firm is investigating potential claims on behalf of shareholders Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) over possible violations of US securities laws due to possible breaches of fiduciary duty by officers of the company. If you have purchased shares of  Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) , contact our law firm right now to protect your rights.

Own shares of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) ? Contact us to protect your rights.

If you have purchased shares of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) , complete the form on this page or call attorney Bill Kyros at 1-800-934-2921 right now to protect your rights. 

Complete the form below for a free no obligation consultation. 

 

Need assistance with this form?